Article Text

other Versions

Download PDFPDF
Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference
  1. William Small Jr1,
  2. Gheorghe Peltecu2,3,
  3. Anastasia Puiu2,3,
  4. Andrei Corha2,3,
  5. Elena Cocîrṭă2,3,
  6. Ruxandra Gabriela Cigăran2,3,
  7. Marie Plante4,
  8. Anuja Jhingran5,
  9. Kyle Stang1,
  10. David Gaffney6,
  11. Monica Bacon7 and
  12. Mary McCormack8
  1. 1Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
  2. 2Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  3. 3Department of Obstetrics and Gynecology, Filantropia Hospital, Bucharest, Romania
  4. 4Department of Obstetrics, Gynecology and Reproduction, CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
  5. 5Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
  6. 6Department of Radiation Oncology, University of Utah, Salt Lake City, Utah, USA
  7. 7Cervical Cancer Research Network, Kingston, Ontario, Canada
  8. 8Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK
  1. Correspondence to Dr William Small Jr, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153-3328, USA; wmsmall{at}


Cervical cancer is the third most common cancer among women worldwide, with a disproportionately high burden of disease in less-developed regions of the world. The Cervix Cancer Research Network was founded by the Gynecologic Cancer InterGroup with a mission to improve outcomes in cervical cancer by enhancing international access to clinical trials, specifically in under-represented, underdeveloped areas. The Cervix Cancer Research Network held its third international educational symposium in Bucharest in 2018 and is the subject of this report. The purpose of this symposium was to advance the international understanding of cervical cancer treatment patterns, to foster recruitment to Cervix Cancer Research Network clinical trials, and identify key Cervix Cancer Research Network clinical trial concepts to improve cervical cancer care worldwide.

  • cervical cancer
  • radiotherapy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @WilliamSmallJr,

  • Contributors All authors contributed to the drafting of this manuscript. All authors have approved the final version prior to submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests MM reports other support from Roche and personal fees from Astra Zeneca; WSJ reports personal fees from Carl Zeiss and other support from NRG Oncology and Merck.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.